HappeningToo topic
Methylprednisolone Sodium Succinate reports
Browse community reports connected to Methylprednisolone Sodium Succinate. These reports can show that other people are describing similar experiences, but they do not prove that Methylprednisolone Sodium Succinate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
33 problems
Abdominal Discomfort while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and abdominal discomfort appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and abdominal pain upper appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and abdominal pain appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and alopecia appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and anxiety appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and back pain appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and chest discomfort appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and cough appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and decreased appetite appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and diarrhea appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and dizziness appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and dyspepsia appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and fatigue appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and headache appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and heart rate increased appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and hives appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and hypotension appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and insomnia appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and itching appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and malaise appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and muscle spasms appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and muscular weakness appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and nausea appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and pain appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and rash appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and shortness of breath appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and skin redness appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and swelling appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and tingling or pins and needles appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and vomiting appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and weakness appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and weight decreased appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Methylprednisolone Sodium Succinate
FDA FAERS contains adverse-event reports in which Methylprednisolone Sodium Succinate and weight increased appear together. This does not establish that Methylprednisolone Sodium Succinate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →